Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice-Reference-Cited by-同舟云学术

Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice

Published:2009-02 Issue:2 Volume:17 Page:278-284
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sallinen Hanna,Anttila Maarit,Narvainen Johanna,Koponen Jonna,Hamalainen Kirsi,Kholova Ivana,Heikura Tommi,Toivanen Pyry,Kosma Veli-Matti,Heinonen Seppo,Alitalo Kari,Yla-Herttuala Seppo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Why did p53 gene therapy fail in ovarian cancer?;Zeimet;Lancet Oncol,2003

3. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat Med,1995

4. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy;Dvorak;J Clin Oncol,2002

5. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels;Yamamoto;Br J Cancer,1997

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage;Frontiers in Pharmacology;2024-02-09

2. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study;European Journal of Radiology;2023-08

3. The vascular endothelial growth factor (VEGF) system as a key regulator of ovarian follicle angiogenesis and growth;Molecular Reproduction and Development;2023-03-26

4. Regression of Human Breast Carcinoma in Nude Mice after Adsflt Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis;Cancers;2022-12-14

5. AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice;Frontiers in Medicine;2022-12-08